trial

Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia

NCTId NCT04033978
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 78 (actual)
Sponsored by Hôpital le Vinatier
Primary completion 2023-06-13
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
78 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-12-17
Primary completion
2023-06-13
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Cognitive Remediationpsychosocial rehabilitation

Sponsors

Hôpital le VinatierLead Sponsor

Investigators

1
FRANCK Nicolas, ProfessorPrincipal Investigator

Sites

1 total
Lyon, France

Facts & assertions

4 sourced
Enrollment
78
Phase
NA
Primary Completion Date
2023-06-13
Status
TERMINATED
relationships
The graph out of here
drug
Cognitive Remediation
drug
psychosocial rehabilitation
drug
lead_sponsor
Hôpital le Vinatier
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
FRANCK Nicolas, Professor
person